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Abstract
Aim: To Improve the treatment of patients with partial edentia and chronic generalized periodontitis by including dental 
implantation to the complex of therapeutic measures.
Materials and methods: There have been presented the results of 240 patients with varying severity degrees of generalized 
periodontitis who underwent surgery on periodontal tissues with dental implantation. The research was conducted at the OCH of 
Ivano-Frankivsk 2007–2017.To improve the efficiency for dental implants and periodontal surgical intervention is necessary to deter-
mine the quality of bone remodeling, identifying markers of bone tissue metabolism.
Results: It was established that in 40,81 % patients the results of research showed markers of bone remodeling indicating 
a high rate of bone formation (25,12±2,23 ng/ml) and a slight increase in rate of resorption marker, which results in low rates of 
bone resorption (8,54±1,23 nmol/L). These patients were not prescribed with osteotropic drugs. 50,83 % of patients with osteopenia 
were noticed to manifest the formation of bone possible raise of bone resorption (10.82±1.34 n/mole), which was the indication for 
antiresorptive medication prescription. In 8,36 % of patients with osteoporosis was observed inhibition of bone formation processes 
(18,05±2,08 ng/ml) and increased resorption indices (15,34±1,87 nmol/L). Medications that stimulate osteogenesis and prevent bone 
resorption were prescribed.
Conclusions: When planning dental implants and periodontal surgical intervention it is necessary to identify markers of 
bone remodeling to assess the structural and functional state of bone tissue and prescribe osteotrophic drugs that promote positive 
postoperative period.
Keywords: generalized periodontitis, dental implants, structural-functional state of bone tissue.
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1. Introduction
The problem of replacing defects in the dentition has remained a topical issue of modern 
theoretical and practical stomatology for more than a decade. The use of traditional prosthetic 
methods is not always effective, especially in persons of working age, who prefer permanent den-
ture structures [1, 2].
Therefore, the actual problem of rehabilitation of patients with dental defects by dental im-
plants is in contrast to traditional methods. Over the past three decades, the method of implanting 
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teeth has become one of the leading in replacing defects in the dentition, aimed not only at the 
restoration of masticatory function, but also at obtaining a high predicted result of orthopedic re-
habilitation of dental patients [3, 4].
At the same time, the combination of defects in dentition with diseases of periodontal tissues, 
especially in young people, complicates the choice of rehabilitation measures, which, together with 
other etiological factors, leads to complications of pathology and shortened use of dentures [5, 6].
The basic method of orthopedic treatment of patients with chronic forms of generalized 
periodontitis (GP), which are usually accompanied by loss of  teeth,  is prosthetic dental bridges, 
which leads to an overload of supporting teeth [7, 8].
Inflammatory and degenerative processes  in periodontal  tissues  in 80 % of cases  involve 
loss of  teeth. At 42.8–87.4 % of  the prevailing  reason  that enhances  inflammatory degenerative 
processes are abnormal overload of the tooth supporting tissues. This greatly aggravates during 
chronic GP: promotes the formation of periodontal pockets, baring the necks of the teeth and in-
flammation in the area of marginal periodontium [9]. 
The general rule for periodontal treatment is to eliminate etiologic factors for the normal-
ization of its properties. The best orthopedic treatment is defined to be a structure with additional 
support on endosseous implants. As a result of redistribution of the load on teeth and implants, the 
occlusal periodontal trauma is reduced, or even eliminated, atrophy of the edentulous jaw areas 
under the influence of functional overload slows by 2–3 times [10, 11]. 
Many periodontists recommended gradual and consistent implementation of all periodontal 
procedures, which significantly increases the length of treatment and is burdensome for working 
patients [12, 13]. 
According to literature, more than 66 % of patients with generalized periodontitis have dif-
ferent structural and functional disorders of the bone tissue that require a more balanced approach 




2. Aim of research
To improve the treatment of patients with partial edentia and chronic generalized periodon-
titis by including dental implantation to the complex of therapeutic measures.
3. Materials and methods
There was conducted a survey of 240 patients with mild, moderate and severe degrees 
of chronic generalized periodontitis with partial edentia of upper and lower jaw, who were later 
treated with comprehensive periodontal treatment using the methods of dental implants. The 
study was conducted at the dental department of Ivano-Frankivsk Regional Hospital 2007–
2017. 340 titanium implants type “U-impl”, Entegra (Innova, Canada), SuperLine (Korea) were 
used. 196 implants were placed in the mandible, 71 implants in the upper jaw, 73 implants 
installed simultaneously on the upper and lower jaws. Implants were inserted using two-stage 
method on included defects – 125 patients (55.8 %), final – 85 patients (37.9 %), combined –  
14 patients (6.3 %).
Clinical examination included: complaints, duration of disease, the incidence of abscesses, 
duration of remission, the presence and nature of chronic physical illness, stress, previously carried 
out treatments, especially the use of antibiotics and surgery and its results, investigated the reasons 
why patients preferred use of dental implants. During the clinical examination there was studied 
the state of the mucous membranes of the mouth, the presence or absence of inflammatory changes, 
density of mucous that cover implants and the bone tissue around them was assessed visually and 
by palpation.
For  an  objective  evaluation  of  periodontium  there  was  used  Schiller-Pisariev’s  test, 
Green-Vermillion oral hygiene index, Muleman bleeding index, Ramfjord index, and Svrakov’s 
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iodine number was determined. There was also examined the state of periodontium using X-ray 
examinations (panoramic radiogram, target radiograms).
According to many authors, the periodontal surgery itself will not create sufficient condi-
tions for the elimination of the pathological process of bone structures in alveolar processes, if not 
to consider the mineral density of the skeleton and feature bone metabolism in people of all ages 
and gender. Reduced bone mineral density may negatively affect the periodontal tissues and reduce 
the terms of functioning implants [15, 16].
The functional state of bone tissue was evaluated by the method of dual-photon X-ray absorp-
tiometry with the help of the apparatus named Challenger (DMS, France). Evaluation of structural 
and functional state of bone was performed, identifying markers of bone tissue metabolism that 
react faster in comparison with densitometry. The most specific marker of bone formation is osteo-
calcin, which reflects the level of circulating bone formation rate [17]. For the quantitative analysis 
of serum osteocalcin level, the immune-ferment test Nordic Bioscience Diagnostics A/SN-MID 
Osteocalcin ELISA (Denmark) was used; referent indices range between 9.6–40.8 ng/ml for men, 
8.4–33.9 ng/ml for women in premenopause, 9.5–48.3 ng/ml for women in post-menopause. Highly 
sensitive and specific marker of bone resorption  is deoxypyridinoline, high  levels of which  in 
urine indicate increased bone resorption. Deoxypyridinoline is released from bone material in 
case of its resorption by osteoclasts and it is a highly sensitive and specific marker of resorption. 
Extremely high urine deoxypyridinoline level indicates increased bone resorption. The level 
of deoxypyridinoline  in urine was defined by  immune-ferment method with  the help of DPD 
EIA KIT (USA); referent indices range between 3.0–7.4 n/mole for women aged 25–44 and 
2.3–5.4 n/mole for men aged 25–44.
In pre-operative course, all the patients underwent the following procedures: elimination of 
local factors, which contributed to the accumulation and activation of the microbial factor effect, 
splinting loose teeth, held local anti-inflammatory therapy, differential osteotrophic therapy, taking 
into consideration the results of the bone remodeling markers study [18, 19].
Surgery for periodontal tissues were performed by using vestybuloplasty by Erokhin, frenu-
loplasty by Limberg, proposed flap operation using osteogenic transplant and autograft bone mar-
row [20, 21]. Dental implantation was carried out by the conventional protocol. Patients underwent 
a gradual periodontal intervention followed by dental implants or surgical intervention on peri-
odontal tissues and implantation carried out in one stage [22].
When phased dental treatment was performed, patients underwent implantation not faster 
than 3 months after periodontal intervention, after elimination of inflammation and stabilization 
of periodontal tissues. Prosthodontic treatment was performed 3–6 months after the surgery. That 
means that period from the start of treatment to the prosthesis averaged no less than 9 months [23].
One-stage surgery was performed after the dental hygiene. The first stage of the operation 
realized curettage of bone pockets, vestybuloplasty, frenuloplasty, performance of proposed flap 
operation using autograft bone marrow and osteogenic transplant, preparing the implant bed, in-
cluding increase of atrophied alveolar ridge bone’s volume. One-stage surgery and implantation 
reduced treatment duration in 1.5–2 times.
Performance of proposed flap operation showed that red bone marrow contains stem cells, 
which have a great potential for growth and proliferation and a great ability to differentiate and 
have immunoregulator and hematopoietic effects. Functionally, they are active cells for production 
of growth factor and regeneration.
Before performing surgery local factors which contribute to the accumulation and activa-
tion of microbial action were eliminated. Before the initiation of the surgery red bone marrow was 
collected from posterior iliac crest bone, occasionally it can also be collected from chest bone, after 
normal sterilization, procedure is carried under local anesthesia. 7.0 ml of red bone marrow is as-
pirated into a bone marrow aspirating syringe which contains 0.5 ml of anticoagulant. Patient may 
feel slight discomfort and pain. The autologous bone marrow is mixed with collagen in 1:1 ratio 
parts by weight. The first stage of the surgery was initiated with the trapezoidal in section with the 












and antibiotics [16]. 
In the postoperative period, all patients were prescribed with anti-inflammatory, detoxifi-
cation, analgesic therapy. Clinical evaluations were conducted in the dynamics before and after 
surgery at 1, 6 and 12 months. X-ray parameter was evaluated before treatment and after 12 months.
According to the degree of severity of chronic generalized periodontitis patients were di-
vided as follows:
Group 1: mild periodontitis – 107 people, including 50 patients, who underwent one-stage 
implantation of periodontology surgical intervention, 57 patients – step by step periodontal treat-
ment followed by implantation;
Group 2: moderate periodontitis – 97 people, including 40 people held one-stage implan-
tation with surgical periodontal treatment , 49 – step by step periodontal treatment followed by 
implantation;
Group 3: severe periodontitis – 36 people 16 – refused implantation due to significant bone 
resorption, 20 patients underwent periodontal surgery and gradually implantation.
4. Results of research 
The results of densitometry showed that: 
In group I – 50 (47 %) patients with bone mineral density ( BMD ) within the normal range, 
57 (53 %) patients with reduced BMD (50 – osteopenia, 7 – osteoporosis).
In the second group – in 38 (39 %) patients with BMD within the normal range, 59 (61 %) 
patients with reduced BMD (osteopenia in 52 patients, osteoporosis in 7 patients).
In the third group, 10 (28 %) patients with BMD within the normal range, 26 (72 %) patients 
with reduced BMD (20 patients – osteopenia in 6 patients – osteoporosis). Thus, only 38 % of pa-
tients with surgery performed on a background of normal BMD, and 62 % – reduced BMD.
In studying the bone tissue metabolism in 50 (47 %) patients of I group with normal bone 
density, there was a slight inhibition of bone formation processes (osteocalcin – 20, 68±2.54 ng/ml) 
and a significant increase in bone resorption rates (dioxypiridipolin – 9.42±1.13 nmol/L). 50 (47 %) 
patients with osteopenia were noticed to manifest the formation of bone tissue within normal 
range (osteocalcin – 22.76±1.15 ng/ml) and a possible raise of bone resorption (dioxypiridipolin – 
10.82±1.34 nmol/L), which was the indication for antiresorptive medication prescription. In 7 pa-
tients (6 %) with osteoporosis was observed inhibition of bone formation processes (osteocal-
cin – 18,05±2,08 ng/ml) and increased resorption indices (dioxypiridipolin – 15,34±1,87 nmol/L). 
Osteocalcin is a marker of bone formation in order to determine the level it uses a plasma blood 
and is measured in ng/ml. Dioxypiridipolin is a resorption marker, which is measured in nmol/L.
The study of bone metabolism in 38 (39 %) patients with Group II with BMD in the nor-
mal range, indicates high bone formation time (osteocalcin 25.12±2.3 ng/ml), and an increase 
in the indicator of resorption marker results in high rates of bone resorption (dioxypiridipolin – 
8.54±1.23 nmol/L). In 59 patients with osteopenia and osteoporosis (61 %), the level of osteocalcin 
was 22.67±1.83 ng/ml, 18.21±1.32 nmol/L, and the increased bone resorption rate (12.87±1 41 for 
dioxypiridipolin) nmol/L; 16.54±1.23 nmol/L).
Metabolism of bone with normal density in 10 (28 %) patients of the III group is char-
acterized by slight constipation of bone formation processes of bone resorption (osteocalcin – 
22,68±2.45 ng/ml) and an increase in bone resorption rates (dioxypiridipolin – 9.42±1.42 nmol/L). 
20 (55, 5 %) patients with osteopenia and 6 with (16,5 %) osteoporosis have bone formation sup-
pressing (osteocalcin – 21.76±2.06 ng/ml, 17.22±1.32 ng/ml) and significantly increased bone re-
sorption (dioxypiridipolin – 10.82±1.21 nmol/L, 15.34±16, 54 nmol/L).
The success of periodontal surgery in recent years is associated not only with the elimina-
tion of periodontal pockets, but also with the usage of the means and methods to stimulate regener-
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eralized periodontitis using bone replacing material enriched in active osteogenic component [16].
  In  patients  of  the  first  group,  during  the  one-stage  dental  implantation  and  periodontal 
surgery (curettage of tooth- gingival pockets, vestybuloplasty, plastic bridle ) and patients who un-
derwent staged surgical treatment of periodontal tissues, followed by dental implants, statistically 
significant differences were not found.
Comparative analysis showed that the occurrence of postoperative patients of this group 
during the one-stage dental implants, periodontal intervention and phased treatment according to 
clinical (redness, swelling, pain, gum color) and radiographic controls differed significantly, elim-
ination of inflammation in periodontal tissues after treatment was observed in 94.8 % of subjects .
In 5–6 days  in  these patients,  signs of  inflammation were observed. Moderate  collateral 
edema in most patients disappeared in 4 days. The mucous flap in the first days after surgery was 
pink or pale pink. A wound was healed with primary intention. Pain during palpation of the mucous 
membrane in the area of wound was not observed. Mobility of teeth that occurred after surgery dis-
appeared in 5–6 weeks. In 1 month after surgery inflammation was not observed, gingival margin 
densely covered dental neck, depth of periodontal pockets decreased by postoperative scarring of 
the mucosal flap and regeneration of bone tissue. Absence of inflammation in the gingival tissues, 
was proved by a sharp decrease of basic periodontal indices in positive dynamics. In 12–18 months 
after treatment clinical and radiological stabilization of periodontal tissue occurred in 83.4 % of pa-
tients. The mucosa around implants became pale pink. Implant mobility was not observed, percus-
sion is not painful. In 2 patients developed periimplantitis, 1 patient in the area of the implant gum 
recession was observed. In one year in this group of patients all implants were retained. Resorptive 
process around implants in 5 years resulted in bone loss in average at 0,8±0,3 mm. 
In group II, patients who underwent staged periodontal treatment followed by dental im-
plants observed positive dynamics of clinical changes and the term regression of clinical signs of 
inflammation was late by an average of 2–3 days, in patients who simultaneously held implantation 
and surgery on periodontal tissues, there was reduced dynamics of periodontal probes and index-
es. In 12–18 months after treatment clinical and radiological stabilization occurred in 80.2 % of 
patients with momentary dental implant and periodontal intervention, 82.8 % – in patients with 
stage treatment. Mucosa in the area of implant was pale pink, percussion was not painful. After 
a one-step dental implants and periodontal intervention in 4 patients developed periimplantitis, 
in 5 patients recession around implants was observed, in 2 patients were no stabilization of the 
implants, thus the signs of disintegration of the implant indicated a need to remove them. In a 
phased treatment periimplantitis developed in 2 patients, gingival recession was not observed, no 
stabilization – in 1 patient. Reduction of the height of the alveolar bone after 5 years in patients 
with momentary conducted dental implants and periodontal intervention amounted to an average 
of 2,4±0,2 mm and with gradual – 1,9±0,1 mm. 
In 20 patients of the third group with severe GP, only gradually periodontal treatment was 
carried out, followed by dental implants. 16 patients of this group were refused implantation due 
to significant bone resorption. As a result of the interference minor periodontal inflammation was 
observed, gingival edges tightly did not cover the neck of the teeth, periodontal pocket depth de-
creased slightly. In 4 patients developed periimplantitis, 2 patients showed gingival recession in the 
area of implants. Resorptive process around implants led to bone loss by an average of 3,2±0,2 mm. 
As the result, the bone loss leaded to the disintegration of four implants.
5. Discussion
It was established that in 40,81 % patients the results of research showed markers of bone 
remodeling indicating a high rate of bone formation (osteocalcin – 25,12±2,23 ng/ml) and a slight 
increase in rate of resorption marker, which results in low rates of bone resorption (dioxypiridi-
polin – 8,54±1,23 nmol/L). These patients were not prescribed with osteotropic drugs. The 50,83 % 
patients with osteopenia were noticed to manifest the formation of bone possible raise of bone 
resorption (dioxypiridipolin – 10.82±1.34 nmol/L), which was the indication for antiresorptive 
medication prescription. In 8,36 % patients with osteoporosis was observed inhibition of bone 
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formation processes (osteocalcin – 18,05±2,08 ng/ml) and increased resorption indices (dioxypiridi-
polin – 15,34±1,87 nmol/L). Medications that stimulate osteogenesis and prevent bone resorption 
were prescribed.
Thus, the results of the study of the bone resorption and formation markers allowed to pre-
scribe – Osteogenon in tablets – 1 tabl., twice per day, duration of treatment is 3 months, purpose-
fully to patients who had inhibited processes of bone formation medications that stimulate bone 
osteogenesis. Patients, who had increased bone resorption were prescribed with antiresorptive – 
Calcium D3 Nycomed – 1 tabl. twice a day for 3 months.
The results of the study indicate that in Group I of patients pathological processes in peri-
odontal tissues develop in 47 % against normal bone tissue, and implantation in patients, who have 
mild generalized periodontitis, can achieve consistent results regardless of the choice of treatment. 
In 39 % of patients of Group II of pathological processes develop on the background of 
normal bone tissue, and in 61 % – pathological processes in periodontal tissues associated with low 
density of bone tissue. Given the slow dynamics of indicators of periodontal probes and indexes, 
there are often postoperative complications in patients undergoing single-stage implantation and 
periodontal surgery. It is advisable in patients with generalized periodontitis of moderate severity 
to conduct a phased surgical treatment of periodontal tissues, followed by dental implants.
Research results show that in 72 % of patients in Group III pathological processes in peri-
odontal tissues develop with a low density of bone tissue and only in 28 % of patients – against the 
background of normal bone tissue. Therefore, in patients with severe GP, only gradually periodon-
tal treatment was performed, followed by dental implants. Although 16 patients in this group were 
denied implantation due to significant resorption of bone tissue. In 4 patients developed periim-
plantitis, 2 patients showed gingival recession in the area of implants. Resorptive process around 
implants led to bone loss by an average of 3,2±0,2 mm. As the result, the bone loss leaded to the 
disintegration of four implants.
Thus, at this stage in the case of the need for dental implantation in patients with generalized 
periodontitis, it is considered to be appropriate to conduct cross-sectional performance of surgical 
intervention on periodontal tissues and dental implants in patients with mild severity, which in 
1.5–2 times shortens the duration of treatment without deterioration of the quality. In patients with 
generalized periodontitis of moderate and severe stages it is recommended to realize phased inter-
ventions following dental implantation to prevent postoperative complications and implant loss. 
In the future, a planned analysis of the parameters of bone tissue metabolism in the dynam-
ics of patients, which have generalized periodontitis, was performed by dental implantation.
This problem was studied by Pavlenko A., Mazur I.. In order to prevent the loss of marginal 
bone around dental implant, there is offered the general scheme of treatment of patients with gen-
eralized periodontitis by ibandronic acid and magnetic-laser therapy that promotes better adapta-
tion of bone to new functional load conditions and reduces bone loss. The authors prove [14] that 
the progression of destructive processes in periodontal tissues is due to structural and functional 
disorders of bone metabolism, which can negatively affect the results of replacement of defects 
in dentition by dental implants. We advise a dental implantation of GP patients in order to obtain 
predicted results to pharmacologically correct metabolic bone disorders in 3–6 months before the 
planned surgical intervention.
Leonenko P. [13] studied features of the physical and mechanical properties of bone in areas 
of implantation in patients with generalized periodontitis and metabolic osteopathy. He revealed 
the presence of local changes in architectonics and strength of BT in patients with GP and meta-
bolic osteopathy. 
In the future, an analysis of the parameters of bone tissue metabolism in the dynamics of pa-
tients, who have generalized periodontitis, which was performed by dental implantation, is planned.
6. Conclusions
1. Dental implantation in patients with mild GP can achieve consistently good results regard-
less of treatment. Simultaneous surgery on periodontal tissues and dental implantation 1.5–2 times 
reduces treatment without reducing its quality.
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terventions, following dental implantation to prevent postoperative complications and implant loss.
3. When planning for dental implants and periodontal surgical intervention it is necessary 
to identify markers of bone remodeling to assess the structural and functional state of bone tissue 
and prescribe osteotrophic drugs that promote positive postoperative period.
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Abstract
The aim of the study: To study and evaluate platelets aggregation activity as primary phase of haemostasis and anti-platelet 
therapy in IHD patients after PCI, depending on the polymorphism of the gene ITGA 2 - C 807T.
Materials and methods: 54 patients who were on a treatment at the clinical hospital “Feofaniya” (Kyiv) and at the Kyiv 
Clinical Hospital on railway transport No. 2 were examined: 20 women and 34 men (mean age - 67.8±7.46 years). The study involved 
patients with stable forms of coronary artery disease (stable angina pectoris II-III) and acute coronary syndrome, with a history of 
percutaneous coronary intervention (PCI). All patients received antiplatelet therapy: acetylsalicylic acid (3.7 %), clopidogrel (9.3 %) 
or a combination of them (87 %).
Functional activity of the platelets was studied on a Biola Aggregation Analyzer laser agrometer. The response to antiplatelet 
therapy was confirmed by the Aggredyne test. The polymorphism of the C807T of the ITGA2 gene was determined by polymerase 
chain reaction (PCR).
Based on the results of the aggregation ability, antiplatelet therapy sensitivity, the patients were divided into two groups: 
group I - individuals with varying degrees of insensitivity to antiplatelet drugs (35 patients), group II – susceptible to treatment 
(19 patients). In each group was analyzed the polymorphism of the gene ITGA2 and features of the functional activity of the platelets, 
depending on the genotype.
Results: In 50 % of patients receiving ASA there was a different degree of non-sensitivity, with respect to thienopyridines – 
this figure was 20 %. Among patients who received dual antiplatelet therapy did not match at least one of the drugs - 83.3%. Among 
the “non responders” 78.9 % had a mutated T-allele, and a homozygous variant for the T allele was recorded in 53.15 % of patients, 





which has a clear link with the polymorphism of the gene ITGA 2. The presence of the T-allele in the genotype of patients with IHD 
is associated with a less adequate platelet response in patients receiving dual antiplatelet therapy for ASA and thienopyridines on 
ADP, which may have an effect on the sensitivity to thienopyridines.
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